NCT01420302

Brief Summary

The LOGIC-Insulin computerized software algorithm will be compared with a nurse-directed protocol, both targeting a blood glucose level of 80-110 mg/dL, in critically ill patients

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2011

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2011

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

August 17, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 19, 2011

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2012

Completed
12.5 years until next milestone

Results Posted

Study results publicly available

August 26, 2024

Completed
Last Updated

August 26, 2024

Status Verified

April 1, 2024

Enrollment Period

4 months

First QC Date

August 17, 2011

Results QC Date

June 20, 2017

Last Update Submit

April 2, 2024

Conditions

Keywords

critical illnessintensive careinsulinglucosealgorithmblood glucose control

Outcome Measures

Primary Outcomes (1)

  • Glycemic Penalty Index (GPI) During the Intervention

    The GPI is an index (ranging from 0 to 100) derived from the blood glucose values that are outside the target level of 80-110 mg/dL, in both the hyperglycemic and the hypoglycemic ranges. The weight of the penalty score of a blood glucose measurement is proportional to the level of deviation from normoglycemia. The GPI is the average of all penalties that are individually assigned to all blood glucose values, based on an optimized smooth penalty function. Higher GPI scores indicate lower efficacy of glycemic control.

    The GPI is the average of all penalties that are individually assigned to all blood glucose values obtained up to 14 days post-randomization, based on an optimized smooth penalty function.

Secondary Outcomes (12)

  • Proportion of Patients With Severe Hypoglycemia (<40 mg/dL) During the Intervention

    up to 14 days post-randomization

  • Incidence of Severe Hypoglycemia (<40 mg/dL) During the Intervention

    up to 14 days post-randomization

  • Blood Glucose Level Per Treatment Group During the Intervention

    up to 14 days post-randomization

  • Hyperglycemic Index (HGI) During the Intervention

    up to 14 days post-randomization

  • Daily Maximal Blood Glucose Difference During the Intervention

    up to 14 days post-randomization

  • +7 more secondary outcomes

Study Arms (2)

LOGIC-Insulin

EXPERIMENTAL

Blood glucose control (80-110 mg/dL) guided by the LOGIC-Insulin algorithm

Procedure: LOGIC-Insulin

Nurse-directed

ACTIVE COMPARATOR

Nurse-directed blood glucose control (80-110 mg/dL)

Procedure: Nurse directed

Interventions

Nurse directed insulin titration to establish glycemic control in the target range of 80-110 mg/dL

Also known as: Active comparator: titration-guidelines supported TGC
Nurse-directed
LOGIC-InsulinPROCEDURE

Blood glucose control (80-110 mg/dL) guided by the LOGIC-Insulin algorithm

Also known as: software guided TGC
LOGIC-Insulin

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or more
  • Admitted to the ICU
  • Already receiving or needing insulin infusion for blood glucose control

You may not qualify if:

  • Not critically ill (eating, not mechanically ventilated)
  • Pregnant or breastfeeding
  • Included in other trial
  • Moribund
  • Diabetes coma
  • No arterial line available

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dept Intensive Care Medicine, University Hospitals Leuven

Leuven, 3000, Belgium

Location

Related Publications (4)

  • van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001 Nov 8;345(19):1359-67. doi: 10.1056/NEJMoa011300.

    PMID: 11794168BACKGROUND
  • Van Herpe T, De Brabanter J, Beullens M, De Moor B, Van den Berghe G. Glycemic penalty index for adequately assessing and comparing different blood glucose control algorithms. Crit Care. 2008;12(1):R24. doi: 10.1186/cc6800. Epub 2008 Feb 26.

    PMID: 18302732BACKGROUND
  • Van Herpe T, De Moor B, Van den Berghe G. Towards closed-loop glycaemic control. Best Pract Res Clin Anaesthesiol. 2009 Mar;23(1):69-80. doi: 10.1016/j.bpa.2008.07.003.

    PMID: 19449617BACKGROUND
  • Van Herpe T, Mesotten D, Wouters PJ, Herbots J, Voets E, Buyens J, De Moor B, Van den Berghe G. LOGIC-insulin algorithm-guided versus nurse-directed blood glucose control during critical illness: the LOGIC-1 single-center, randomized, controlled clinical trial. Diabetes Care. 2013 Feb;36(2):188-94. doi: 10.2337/dc12-0584. Epub 2012 Sep 6.

Related Links

MeSH Terms

Conditions

Critical IllnessInsulin Resistance

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Results Point of Contact

Title
Professor Greet Van den Berghe
Organization
Department and Laboratory of Intensive Care Medicine KULeuven/UZLeuven

Study Officials

  • Dieter Mesotten, MD, PhD

    KU Leuven

    STUDY DIRECTOR
  • Greet Van den Berghe, MD, PhD

    KU Leuven

    PRINCIPAL INVESTIGATOR
  • Tom Van Herpe, Eng, PhD

    KU Leuven

    PRINCIPAL INVESTIGATOR
  • Bart De Moor, Eng, PhD

    KU Leuven

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Algorithm-guided versus Nurse directed Blood Glucose Control
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Head of Dept Intensive Care Medicine

Study Record Dates

First Submitted

August 17, 2011

First Posted

August 19, 2011

Study Start

August 1, 2011

Primary Completion

December 1, 2011

Study Completion

March 1, 2012

Last Updated

August 26, 2024

Results First Posted

August 26, 2024

Record last verified: 2024-04

Locations